ProMIS Neurosciences Appoints Ivana Rubino Chief Commercial Officer

ProMIS Neurosciences has appointed Ivana Rubino, Ph.D., as Chief Commercial Officer. The appointment is effective October 5, 2026. Rubino was also granted a stock option for 80,000 shares at $9.37 under the company's 2026 Inducement Plan.